- Home
- GSK vs BBVA Comparison
GSK vs BBVA Comparison
Compare GSK & BBVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- BBVA
- Stock Information
- Founded
- GSK 1715
- BBVA 1857
- Country
- GSK United Kingdom
- BBVA Spain
- Employees
- GSK N/A
- BBVA N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- BBVA Commercial Banks
- Sector
- GSK Health Care
- BBVA Finance
- Exchange
- GSK Nasdaq
- BBVA Nasdaq
- Market Cap
- GSK 86.1B
- BBVA 83.4B
- IPO Year
- GSK N/A
- BBVA N/A
- Fundamental
- Price
- GSK $38.04
- BBVA $14.92
- Analyst Decision
- GSK Hold
- BBVA
- Analyst Count
- GSK 3
- BBVA 0
- Target Price
- GSK N/A
- BBVA N/A
- AVG Volume (30 Days)
- GSK 4.9M
- BBVA 2.7M
- Earning Date
- GSK 07-30-2025
- BBVA 07-30-2025
- Dividend Yield
- GSK 4.23%
- BBVA 5.25%
- EPS Growth
- GSK N/A
- BBVA 29.44
- EPS
- GSK 0.98
- BBVA 1.91
- Revenue
- GSK $40,735,668,430.00
- BBVA $34,613,056,625.00
- Revenue This Year
- GSK $6.70
- BBVA $16.21
- Revenue Next Year
- GSK $5.42
- BBVA $2.08
- P/E Ratio
- GSK $18.78
- BBVA $7.82
- Revenue Growth
- GSK 2.57
- BBVA 12.90
- 52 Week Low
- GSK $31.72
- BBVA $9.23
- 52 Week High
- GSK $44.67
- BBVA $15.67
- Technical
- Relative Strength Index (RSI)
- GSK 40.16
- BBVA 49.44
- Support Level
- GSK $40.67
- BBVA $14.84
- Resistance Level
- GSK $42.63
- BBVA $15.67
- Average True Range (ATR)
- GSK 0.66
- BBVA 0.23
- MACD
- GSK -0.41
- BBVA -0.07
- Stochastic Oscillator
- GSK 4.67
- BBVA 11.76
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About BBVA Banco Bilbao Vizcaya Argentaria S.A.
Despite its Spanish origins, BBVA generates only around a quarter of its profits in Spain. We expect that on a normalised basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.